Polyglactin 910 — Synthetic Absorbable Surgical Suture
DemeTECH's Polyglactin 910 suture is a synthetic absorbable, sterile, surgical suture composed of copolymers made from 90% glycolide and 10% L-lactide. Polyglactin 910 suture is available in violet or colorless from sizes USP 8-0 to USP 2.
Polyglactin 910 meets all requirements established by the United States Pharmacopeia (USP) and the European Pharmacopoeia (EP) for Synthetic Absorbable Surgical Sutures (except for an occasional oversize in some gauges).
Polyglactin 910 Suture is indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic surgery, but not for use in cardiovascular or neurological tissue.
More DetailsUnderstanding how Polyglactin 910 behaves once placed in the body
A slight tissue inflammation may occur when Polyglactin 910 Sutures are placed in tissue, which is characteristic of a foreign body response. This is followed by gradual encapsulation by connective tissue, after which absorption by hydrolysis begins.
Progressive loss of tensile strength and eventual absorption occurs as the polymer degrades. Absorption begins as a loss of tensile strength without appreciable loss of mass, continuing until the suture is completely absorbed between 56 and 70 days.
A slight tissue inflammation occurs, characteristic of foreign body response, followed by gradual encapsulation of the suture by fibrous connective tissue.
The polymer degrades to glycolic acid (or glycolic and lactic acids), which are subsequently absorbed and metabolized by the body — a clean, predictable breakdown pathway.
Complete loss of original tensile strength occurs by 5 weeks post implantation. Absorption is essentially complete between 56 and 70 days after placement.
DemeTECH's Polyglactin 910 sutures are manufactured from synthetic copolymers for predictable, reliable absorption
DemeTECH's Polyglactin 910 suture is a synthetic absorbable, sterile, surgical suture composed of copolymers made from 90% glycolide and 10% L-lactide. The chemical formula is (C₂H₂O₂)m(C₃H₄O₂)n. Clinical trials show that after two weeks, approximately 75% of initial strength remains; at four weeks, approximately 25% remains. Polyglactin 910 is nonantigenic, eliciting only mild tissue reactivity during the absorption process. Coated Polyglactin 910 sutures facilitate easy tissue passage, precise knot placement, smooth tie down, and a decreased tendency to irritate tissue.
Composed of 90% glycolide and 10% L-lactide copolymers (C₂H₂O₂)m(C₃H₄O₂)n, providing consistent and predictable material properties across every suture.
Clinical trials confirm ~75% of initial strength at 2 weeks, ~50% at 3 weeks post-op, and ~25% at 4 weeks — a well-characterised, predictable strength profile.
DemeTECH's Polyglactin 910 is nonantigenic and elicits only mild tissue reactivity during the absorption process, supporting a cleaner healing environment.
Supplied in violet or colorless, from sizes USP 8-0 to USP 2, giving surgeons flexibility to select the most appropriate option for each procedure.
Coated to create a smoother suture that passes through tissue readily, with a decreased tendency to irritate tissue and greater overall tensile strength.
Enables precise knot placement and smooth tie-down, giving surgeons confident, secure closures that hold reliably through the critical wound-healing period.
Contact our team for product availability, pricing, and technical specifications tailored to your requirements.